Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS.
Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF
Coral Gables-based Catalyst Pharmaceuticals is betting its future on a drug called Firdapse, which is used to treat a rare neurological disease called LEMS. PETER ANDREW BOSCH MIAMI HERALD STAFF

Catalyst Pharmaceuticals reports second-quarter net loss, plans to submit new drug for FDA approval

August 11, 2015 04:43 PM

UPDATED August 11, 2015 04:44 PM

More Videos

  • DealBook Conference: AT&T, Uber and President Cuban?

    The best moments from the annual DealBook conference, where executives from companies ranging from stalwarts to upstarts offered their views on the business world today, and tomorrow.